爱企查企业服务平台为您提供详细的KAPSPARGO商标分析报告,了解该商标注册成功率,商标注册类别风险分析,商标风险评估分析等,帮助用户规避商标注册风险和商标侵权风险,为企业做好品牌保护.
Kapspargo Sprinkle 英文名: Metoprolol Succinate Extended-release Capsules 剂型: 胶囊剂 规格: 200mg(以酒石酸美托洛尔计) 单位: --- 持证商: Sun Pharmaceutical Industries, Inc. 上市国家: 美国橙皮书 什么是参比制剂?参比制剂用于仿制药的开发以证明仿制产品与原研产品的质量是否一致,是仿制药开发成败的关键...
Kapspargo Sprinkle 英文名: Metoprolol Succinate Extended-release Capsules 剂型: 胶囊剂 规格: 100mg(以酒石酸美托洛尔计) 单位: --- 持证商: Sun Pharmaceutical Industries, Inc. 上市国家: 美国橙皮书 什么是参比制剂?参比制剂用于仿制药的开发以证明仿制产品与原研产品的质量是否一致,是仿制药开发成败的关键...
药品通用名 琥珀酸美托洛尔缓释胶囊剂 英文名称 Metoprolol Succinate Extended-release Capsules 商品名 Kapspargo Sprinkle 规格 100mg(以酒石酸美托洛尔计) 剂型 胶囊剂 持证商 Sun Pharmaceutical Industries, Inc. 备注1 未进口原研药品 备注2 美国橙皮书 来源分类 暂无权限 来源批次 暂无权限 ...
美国FDA橙皮书数据库提供Kapspargo Sprinkle药品的详细信息,包括申请号210428,中文名称琥珀酸美托洛尔,商标名,剂型/给药途径,参比制剂,企业名称Spil,批准日期等信息,以及Kapspargo Sprinkle的专利和市场独占信息的查询.
Kapspargo Sprinkle Lopressor Toprol XL Ther. Class. antianginals antihypertensives Pharm. Class. beta blockers Indications Indications Indications Hypertension. Angina pectoris. Prevention of MI and decreased mortality in patients with recent MI. Stable, symptomatic (class II or III) heart failure due ...
High Alert Medication:This medication bears a heightened risk of causing significant patient harm when it is used in error. Genetic Implications: Pronunciation: me-toe-proe-lole Trade Name(s) Kapspargo Sprinkle Lopressor Toprol XL Ther. Class. ...
仿制药参比制剂数据库提供了琥珀酸美托洛尔缓释胶囊参比制剂的详细信息,包括美国橙皮书的商品名Kapspargo Sprinkle,英文名称Metoprolol Succinate Extended-release Capsules,序号,规格,剂型,持证商Sun Pharmaceutical Industries, Inc.,目录分类等琥珀酸美托洛尔缓释胶囊参
Kapspargo Sprinkle Usual initial dose: 100 mg PO qDay, given in a single dose; gradually increase dose at weekly intervals until optimum clinical response is achieved or there is a pronounced slowing of the heart rate Dosages above 400 mg/day have not been studied If treatment is to be dis...
Future home of something quite cool. If you're thesite owner,log into launch this site If you are avisitor, check back soon.